REDWOOD CITY, Calif., Sept. 28, 2005 /PRNewswire-FirstCall/ -- Genomic Health, Inc. today announced the pricing of its initial public offering of 5,016,722 shares of its Common Stock at $12.00 per share. J.P. Morgan Securities Inc. and Lehman Brothers Inc. acted as joint book-running managers for this offering, and Piper Jaffray & Co., Thomas Weisel Partners LLC and JMP Securities LLC acted as co-managers.
All of the shares were sold by the Company. The Company has granted the underwriters an option to purchase an additional 752,508 shares to cover over- allotments, if any. Genomic Health's Common Stock will be traded on the Nasdaq National Market beginning September 29, 2005 under the symbol "GHDX." The offering is expected to close on October 4, 2005, subject to customary closing conditions.
A Prospectus relating to these securities may be obtained from J.P. Morgan Securities Inc., Prospectus Department, One Chase Manhattan Plaza, New York, NY 10081, telephone (212) 552-5164, or from Lehman Brothers Inc., c/o ADP Financial Services, Prospectus Fulfillment, 1155 Long Island Avenue, Edgewood, NY 11717 or by fax at (631) 254-7268 or email request to email@example.com or firstname.lastname@example.org.
About Genomic Health
Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions.
Source: Genomic Health, Inc.